Literature DB >> 31644856

Rituximab or Cyclosporine for Membranous Nephropathy.

Claudio Ponticelli1, Gabriella Moroni2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31644856     DOI: 10.1056/NEJMc1910393

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Rituximab in Membranous Nephropathy.

Authors:  Philipp Gauckler; Jae Il Shin; Federico Alberici; Vincent Audard; Annette Bruchfeld; Martin Busch; Chee Kay Cheung; Matija Crnogorac; Elisa Delbarba; Kathrin Eller; Stanislas Faguer; Kresimir Galesic; Siân Griffin; Martijn W F van den Hoogen; Zdenka Hrušková; Anushya Jeyabalan; Alexandre Karras; Catherine King; Harbir Singh Kohli; Gert Mayer; Rutger Maas; Masahiro Muto; Sergey Moiseev; Balazs Odler; Ruth J Pepper; Luis F Quintana; Jai Radhakrishnan; Raja Ramachandran; Alan D Salama; Ulf Schönermarck; Mårten Segelmark; Lee Smith; Vladimír Tesař; Jack Wetzels; Lisa Willcocks; Martin Windpessl; Ladan Zand; Reza Zonozi; Andreas Kronbichler
Journal:  Kidney Int Rep       Date:  2021-01-13

2.  Salvianolic acid B attenuates membranous nephropathy by activating renal autophagy via microRNA-145-5p/phosphatidylinositol 3-kinase/AKT pathway.

Authors:  Junqi Chen; Qinghong Hu; Yini Luo; Lina Luo; Hua Lin; Dandan Chen; Yuan Xu; Bihao Liu; Yu He; Chunling Liang; Yaoyu Liu; Jiuyao Zhou; Junbiao Wu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.